USFDA approval for its ANDA Aripiprazole Tablets in six strengths…..
What uptick / opportunity does it bring to Aurobindo?
It is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Abilify Tablets, of Otsuka Pharmaceutical Company and which has an estimated market size of $7.3 billion in the United States, for the twelve months ended August 2015, according to IMS data.
Abilify is one of the blockbuster drugs off the patent list in 2015
| Subscribe To Our Free Newsletter |
